We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nobel Prize Winner to Address Annual Pathology Meeting

By Labmedica staff writers
Posted on 20 Sep 2006
Print article
The pathologist's role in patient safety, advances in molecular pathology for early disease diagnoses, and the newest clinical laboratory tests are among the many issues to be explored at the 2006 Annual Meeting of The American Society for Clinical Pathology (ASCP), October 18-22, in Las Vegas (Nevada, USA). Nobel Prize winner Louis J. Ignarro, Ph.D., of the University of California, Los Angeles (UCLA, USA), will give the opening keynote address.

Dr. Ignarro will present a historical perspective of his research, including his experiences in Stockholm as he received the Nobel Prize. His experimentation led to the discovery that nitric oxide is the neurotransmitter responsible for penile erection. Dr. Ignarro's research made it possible for medical professionals to understand what protects the cardiovascular system against pathologic conditions, such as hypertension and atherosclerosis. His studies have also resulted in a new understanding of cardiovascular system pathology, and contributed to the development of a variety of pharmaceuticals, including Viagra (sildenafil, Pfizer).

On October 20, Ralph L. Nachman, M.D., professor and chair, department of medicine Weill Cornell Medical College (New York, NY, USA), will give the scientific keynote address entitled "To Clot or Not to Clot: a Clinical Challenge.” He will talk about how chronologic advances, new discoveries in molecular genetics, and serendipity have furthered the understanding of coagulation and fibrinolytic systems. Dr. Nachman will address hypercoagulable states from their molecular biology to their clinical consequences.

Ralph H. Hruban, M.D., professor, pathology and oncology, The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins University (Baltimore, MD, USA), will present the Arthur Purdy Stout Keynote address on October 21. His lecture is entitled "Tumors of the Pancreas: From Genes to Diagnostic Pathology.” He will present an overview of the pathobiology of pancreatic neoplasia with emphasis on the application of the latest technologies to diagnose pancreatic pathology.

At the meeting, pathologists will learn about other new topics and concepts, take interactive and dynamic courses, and share ideas and strategies to deal with the toughest challenges in pathology. There will be numerous exhibits displaying state-of-the-art technology, products, and services for pathologists and laboratory professionals.



Related Links:
American Society for Clinical Pathology
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Human Insulin CLIA
Human Insulin CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.